Hepatitis Research and Treatment / 2013 / Article / Tab 1

Clinical Study

Evaluation of the Significance of Pretreatment Liver Biopsy and Baseline Mental Health Disorder Diagnosis on Hepatitis C Treatment Completion Rates at a Veterans Affairs Medical Center

Table 1

Baseline characteristics.

VariablesCohort ( )

Gender
 Male, (%)367 (98%)
 Female, (%)8 (2%)
Race/ethnicity
 Black, (%)192 (52%)
 White, (%)141 (38%)
 Unknown, (%)22 (6%)
 Other, (%)20 (5%)
Genotype
 1 and 4, (%)301 (80%)
 2 and 3, (%)58 (15%)
 Not documented, (%)12 (3%)
 Mixed, (%)4 (1%)
Age (years), median (range)53 (27–77)
BMI (kg/m2)29.2 (18.7–59.5)
 Obese (BMI 30 to 39.9), (%)149 (40%)
 Overweight (BMI 25 to 29.9), (%)137 (37%)
 Morbidly obese (BMI ≥ 40), (%)15 (4%)
HCV VL RNA (IU/mL), median (range)1,350,000 (344–25,400,000)
Diabetes diagnosis, (%)97 (26%)
HIV diagnosis
 No, (%)253 (68%)
 Not assessed or not documented, (%)87 (23%)
 Yes, (%)35 (9%)
Course of therapy
 1st, (%)252 (67%)
 2nd, (%)92 (25%)
 3rd or more, (%) 31 (8%)
Concomitant substance abuse, (%)11 (3%)
Concomitant alcohol use, (%)30 (8%)
Alb (g/dL), median (range)4.2 (2.7–5.3)
Hgb (g/dL), median (range)14.6 (9.8–18.2)
INR, median (range)1.0 (0.86–1.78)
PLT (THO/uL), median (range)197.5 (42–439)
SCr (mg/dL), median (range)1.0 (0.6–3.5)
Tbili (mg/dL), median (range)0.8 (0.1–2.9)
WBC (THO/uL), median (range)6.2 (2.2–14.9)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.